common infections in tropical regionreviews.berlinpharm.com/20180303/common_infections_in... ·...
TRANSCRIPT
2/21/2018
1
Methee Chayakulkeeree , MD. PhD.
D i v i s i o n o f I n f e c t i o u s D i s e a s e s & T r o p i c a l M e d i c i n e
D e p a r t m e n t o f M e d i c i n e
F a c u l t y o f M e d i c i n e S i r i r a j H o s p i t a l
M a h i d o l U n i v e r s i t y
Common Infections in Tropical Region
Areas lie between the Tropic of Cancer and Tropic of Capricorn belts
Tropical Region
Warm 25-28 °C
Wet and dry season
Rainy
A 45-year-old female
Poorly controlled type 2 DM presented with a 1-week fever and right upper quadrant abdominal pain. She had a history of chronic intermittent abdominal dyscomfort for a year. CT abdomen showed multiple ring enhancing lesions at the liver and gall stones.
Needle aspiration and stain showed gram-negative rod with bipolar staining, gram-positive cocci and gram-positive bacilli.
Melioidosis titer was positive with titer 1:64. What is the diagnosis?
A. Pyogenic liver abscess
B. Melioidosis
C. Primary bacteremic liver abscess
D. Liver metastasis
E. Fasciola hepatica infestation
A 45-year-old female
Poorly controlled type 2 DM presented with a 1-week fever and right upper quadrant abdominal pain. She had a history of chronic intermittent abdominal dyscomfort for a year. CT abdomen showed multiple ring enhancing lesions at the liver and spleen with gall stones.
Needle aspiration and stain showed gram-negative rod with bipolar staining.
Melioidosis titer was negative. What is the diagnosis?
A. Pyogenic liver abscess
B. Melioidosis
C. Primary bacteremic liver abscess
D. Liver metastasis
E. Fasciola hepatica infestation
Liver Abscess
Pyogenic liver abscess – 80% Direct spread: biliary tract, portal circulation or bowel
Hematogenous seeding
Amoebic liver abscess – 10% E. histolytica
Fungal liver abscess – 10% Candida spp.
Liver Abscess
Pyogenic liver abscess Direct spread: biliary tract, portal circulation or
bowel:
Mixed organisms: E. coli, anaerobes e.g. Bacteroides fragilis, Actinomyces israelii
Hematogenous seeding: - monomicrobial
Burkholderia pseudomallei
Klebsiella pneumoniae
Viridans streptococci: S. anginosus group (S. anginosus, S. intermidius, S. constellatus)
Blood culture and abscess fluid examination
2/21/2018
2
Pus Gram Stain
Polymicrobial
Actinomyces
B. pseudomallei K. pneumoniae
S. intermediate
Pus Gram Stain
Melioidosis
Caused by a gram-negative bacterium
Burkholderia pseudomallei
Category B bioterrerism
N Eng J Med 2012;367:1035-44
Risk factors
Incubation 1-21 days (average 9 days), longest 62 yr.
75 to 81% rainy season
Incidence peaks between age 40 and 60 years
80% of patients have one or more risk factors
Diabetes (23 to 60%)
Heavy alcohol use (12 to 39%)
Chronic pulmonary disease (12 to 27%)
Chronic renal disease (10 to 27%)
Thalassemia (7%)
Glucocorticoid therapy (<5%)
Cancer (in 5%)
Clinical Classification
Disseminated septicemic melioidosis
Non-disseminated septicemic melioidosis
Multifocal localized melioidosis
Localized melioidosis
Probable melioidosis
Subclinical melioidosis
Clinical Manifestations
N Eng J Med 2012;367:1035-44
2/21/2018
3
Clinical Manifestations
Pneumonia (51%)
Genitourinary infection (14%)
Skin infection (13%)
Bacteremia without evident focus (11%)
Septic arthritis or osteomyelitis (4%)
Neurologic involvement (3%)
Internal-organ abscesses and secondary foci in the lungs, joints, or both - common
Clinical Manifestations
Acute fulminant septic illness to a chronic infection (symptoms for >2 months for 11% of cases)
May mimic cancer or tuberculosis – the great imitator
Over half of patients have bacteremia on presentation, and septic shock develops in approximately one fifth
Clinical Manifestations
Suppurative parotitis 40% in children in Thailand and Cambodia (extremely rare in Australia)
Prostatic melioidosis - 20% of male (in Australia)
neurologic melioidosis Brain-stem encephalitis w/wo cranial-nerve palsies (esp. CN VII)
Myelitis with peripheral motor weakness
Recurrent melioidosis occurs 1 in 16 patients, often in the first year About 25% reinfection
75% relapse
Mortality 40%
A 45 years old female, DM
A midddle-age man with diabetes
มงคล แซ่ภู,่มงคล แซ่ภู,่
Mongkol Sae-Phoo,Mongkol Sae-Phoo,
5273809752738097
Page: 20 of 37Page: 20 of 37
Siriraj Hospital Siriraj Hospital
DefinitionDefinition
ABDOMINAL CTAABDOMINAL CTA
28/9/2553 12:03:11 28/9/2553 12:03:11
THK: 7THK: 7
IM: 20IM: 20
cm
cm
Mongkol Sae-Phoo,Mongkol Sae-Phoo,
Page: 8 of 40Page: 8 of 40 IM: 8IM: 8
Mongkol Sae-Phoo,Mongkol Sae-Phoo,
Page: 10 of 40Page: 10 of 40 IM: 10IM: 10
A midddle-age man with diabetes
2/21/2018
4
Diagnosis
Culture is a must
Serologic testing alone is inadequate for confirming the diagnosis, especially in endemic regions (> 50% positive)
Empirical therapy for melioidosis should not be continued if B. pseudomallei is not detected in adequate cultures of specimens obtained before therapy
Molecular identification – PCR, sequencing is useful
Treatment
Initial intensive therapy (10-14 days)
Ceftazidime 50 mg/kg of body weight (up to 2 g), every 6–8 hr
Meropenem 25 mg/kg (up to 1 g), every 8 hr
Imipenem 25 mg/kg (up to 1 g), every 6 hr
Oral eradication therapy (3-6 months)
TMP-SMX - based on body weight
> 60 kg: TMP/SMX DS 2 tabs q 12 hr
40–60 kg: TMP/SMX SS 3 tabs q 12 hr
< 40 kg, adult TMP/SMX SS 2 tabs q 12 hr
< 40 kg, child 8 mg of TMP/kg and 40 mg of SMX/kg, every 12 hr
N Eng J Med 2012;367:1035-44
Treatment
≥ 4 weeks IV therapy may be necessary in patients with severe disease
The addition of TMP/SMX 8/40 mg per kg (up to 320/1600 mg) q 12 h should be considered in neurologic, prostatic, bone, or joint melioidosis
Second-line oral therapy
Amoxicillin–clavulanate or doxycycline
Amoxicillin–clavulanate 20 mg of amoxicillin and 5 mg of clavulanate per kg 3 times daily (high rate of relapse)
Community-acquired Klebsiella pneumoniae invasive infection
magA gene is associated with HMKP
Liver abscess, endophthalmitis, osteomyelitis, pneumonia, brain abscess/meningitis
(distinctive syndrome)
Bacteremia-common
Prevalent in East and Southeast Asians: Taiwan, Korea, Thailand, Singapore
Kawai T. Clin Infect Dis 2006;42:1359–61
Klebsiella pneumoniae genotype K1
Hypermucovicous Klebsiella pneumonia (HMKP): K1
String test
A 70-year-old woman
Presented with prolonged fever for 1 month
Significant weight loss
Non-productive cough
Desaturation
AntiHIV-negative
2/21/2018
5
Imagings
CXR CT Chest
Serum cryptococcal antigen-positive 1:32
A Man with Abdominal Mass
A 66-year-old man
Diagnosed normal pressure hydrocephalus (NPH) and vascular dementia for 2 years post programmable VP shunt
Chronic headache for 1 years
Chronic abdominal pain with palpable mass for 6 months
Imagings
CT abdomen CT brain Aspiration of pseudocyst Culture: Cryptococcus gattii
CSF cryptococcal antigen > 1:1024
Serum cryptococcal antigen 1:8
Progress
A 88-year-old woman
Diagnose vascular dementia for 1 year
Headache and alteration of consciousness for 2 months
Seizure
Brain tissue from autopsy Encapsulated budding yeasts
Identification of C. gattii
C. neoformans vs. C. gattii
L-canavanine glycine bromothymol blue (CGB) agar
2/21/2018
6
C. gattii Gone Wild on World Tour
Springer DJ, et al. Emerging Infectious Diseases 2016;1
C. gattii was thought to be restricted to tropical and subtropical regions, BUT not any more
C. gattii Outbreak in Vancouver Island 1999-2007
Emerg Infect Dis 2010 Feb;16(2):251-7
Characteristic Total
No. of case• Persons living on Vancouver, n(%)
218161 (73.9)
Age, year mean (range) 58.7 (2-92)
Clinical assessment, n(%)• Respiratory syndrome• CNS syndrome• Respiratory and CNS syndrome• Other/unknown• Asymptomatic
167 (76.6)17 (7.8)
22 (10.1)12 (5.5)16 (7.3)
Immunocompromised, n(%) 70 (38)
- Long incubation period: 6 (2-11) months- VGIIa 86.3 %, VGI 6.5%
Clinical Characteristics
C. neoformans C. gattii
Host (mainly in) Immunocompromised Immunocompetent
Organ involvement CNS > Lungs Lungs > CNS
Complications
• Cryptococcoma• Hydrocephalus• Large lesion
Less More
Antifungal susceptibility
More susceptible to fluconazole
Less susceptible to fluconazole
Treatment response Good Required more surgicalintervention and prolonged
antifungal treatment
• Clin Microbiol Rev 2014;27(4):980-1024., IDSA guideline 2010 for cryptococcosis
• Clin Infect Dis 1995;21(1):28-34, Braz J Mcrobiol 2015;46(4):1125–33
A 17-year old man
• β Thal/HbE disease
• Chronic leg ulcer for 2 months after flood
Pythium insidiosum
antibody- Positive
Human pythiosis (Pythiosis insidiosi)
• Organism: Pythium insidiosum
• A water mold closely related to algae more than fungi (Oomycetes)
• Non-septate broad hyphae with branching
• Produce sporangia
• Aquatic motile biflagellated zoospore
Zoospore
2/21/2018
7
Epidemiology & Pathogenesis of Human Pythiosis
Tropical and subtropical regions
Mostly in Thailand
Direct contact to contaminated sources
Risk factors
Hematological diseases
Thalassemia-hemoglobinopathy syndrome – mostly
Non-thalssemia: PNH, AA, AML, ITP
Mechanism: unknown (may be related to iron overload?)
No underlying disease (ocular form)
5 months later
Angiography
Charoen Kladsuk,Charoen Kladsuk,529628565296285615/04/1415/04/1441 YEAR41 YEARFF
Page: 2 of 2Page: 2 of 2
Siriraj Hospital Siriraj HospitalLEG CTALEG CTA
AW electronic filmAW electronic film 19/06/55 3:04:33 19/06/55 3:04:33
2258855222588552------------------
IM: 3057IM: 3057
W: 256W: 256C: 128C: 128
Z: 1Z: 1
cm
cm
Angiography
Clinical Syndromes of Pythiosis
Human pythiosis in Thailand (102 cases: 1985-2003)
Localized forms
Cutaneous/subcutaneous pythiosis (5%)
Ocular pythiosis (33%)
Systemic forms
Vascular pythiosis (59%)*
Disseminated pythiosis (3%)
Overall mortality 40%
Limb amputation 78%
Enucleation/evisceration 78% (ocular form)
Human Pythiosis in Thailand. CID 2006:43, 569-76.
Diagnosis of Human Pythiosis
Direct microscopic examination
Culture (gold standard)
Histopathology
Serology***
Immunodiffusion test (ID)
Immunochromatographic test (ICT)
Molecular identification
PCR
2/21/2018
8
Treatment
Surgical treatment Radical surgery : the main effective treatment
Vascular pythiosis :
Resection of infected arteries
BK, AK amputation
Aneurysmectomy
Thrombo-embolectomy not recommended
Grossly normal looking not indicate adequate excision
Microscopic demonstration of organism-free surgical margin needed***
Medical Treatment
Medical treatment alone is ineffective
Pythium immunotherapy
SSKI (saturated solutions of potassium iodide)
Itraconazole+terbinafine
2-year-old boy with periorbital cellulitisextended to nasopharynx and maxillay sinus
1 year course of Itraconazole
plus terbinafine
Dengue vaccine
Dengvaxia® (CYD-TDV)
Live attenuated vaccine (4 subtypes)
3 injections: 0, 6, 12 months
Approved in 9-45 years old
Moderate efficacy: 65%
DEN3-4 (75%) > DEN1 (50%) > DEN2 (35%)
Higher efficacy in serological evidence of previous dengue exposure
Decreased severity (90%) and decrease hospitalization 80%
Capeding MR, et alLancet. 2014;384(9951):1358-65., Villar L, et al. N Engl J Med. 2015;372(2):113-23.
November 2017Persistent protective benefit against dengue fever in those who had prior infection.
For those not previously infected by dengue virus, in the longer term, more
cases of severe disease could occur following vaccination upon a
subsequent dengue infection.
Malaria
P.ovale: mostly in Africa (especially West Africa) and theislands of the western Pacific
> 90% Pf
> 90% Pv
Mixed
In Thailand: P. vivax 56.8%, P. falciparum 42.5%
Plasmodium Life Cycle
Erythrocytic stage:
P. falciparum - irregular (about 48 h)
P. vivax and P. ovale - 48 h
P. malariae - 72 h
P. knowlesi - 24 h
2/21/2018
9
Morphology of Plasmodium spp.
P. falciparum
IP: 12 days
P. vivax
IP: 13 days
P. malariae
IP: 17 days
P. ovale
IP: 28 days
P. knowlesi
IP: 12 days
Parasitized RBC = normal RBC
RBCs contain immature trophozoites (ring form)
Maurer’s dots
16-32 merozoites/schizont
Parasitized RBC (young) > normal RBC
Trophozoites amoeboid form
RBCs contain all stages
Schuffner’s dots
12-24 merozoites/schizont
Hypnozoites in liver*
Parasitized RBC = normal RBC
Trophozoites amoeboid form
RBCs contain all stages
Trophozoites – band shape
6-12 merozoites/schizont, Rosette
Parasitized RBC slightly > normal RBC
Oval RBC with fimbriae
RBCs contain all stages
Schuffner’s dots (James’ dot)
8-14 merozoites/schizont
Hypnozoites in liver
Parasitized RBC = normal RBC
Trophozoites pigment spreads inside
cytoplasm, band maybe seen (like P. malariae)
RBCs contain all stages
Multiple invasion and high parasitemia (like P.
falciparum)
Rings Trophozoites Schizonts Gametocytes
IP: incubation period
What you should know?
New species P. knowlesi: Malaysia, Indonesia, Phillippines, Thailand (Yala, Krabi, Prachuab kirikhan, Chantaburi)
Knowlesi malaria can be severe
Erythrocytic stage of P. knowlesi = 24 h (shortest)
P. vivax infection can be severe (increased mortality)
P. vivax and P. ovale relapse weeks to months later (hypnozoites)
Treating the hypnozoite with a second agent (primaquine)
When P. vivax and P. ovale are transmitted via blood, treatment with primaquine is not necessary
No sporozoites that form hypnozoites in blood
Clinical Laboratory
Impaired consciousness
Prostration
Multiple convulsions
Deep breathing and respiratory distress
Acute pulmonary edema and acute respiratory distress syndrome
Circulatory collapse or shock
Acute kidney injury
Clinical jaundice plus evidence of other vital organ dysfunction
Abnormal bleeding
Hypoglycemia (< 40 mg/dl)
Metabolic acidosis
Severe normocytic anaemia (hemoglobin < 5 g/dl)
Hemoglobinuria
Hyperlactataemia (lactate > 5 mmol/l)
Renal impairment (Cr > 3 mg/dl)
Pulmonary oedema (radiological)
Severe Falciparum Malaria
Parasitemia ≥ 5% or schizontemia is
associated with severity
Severe Vivax Malaria
Similar to those of severe P. falciparum malaria and can be fatal
Severe anemia and respiratory distress occur at all ages
Severe anaemia is particularly common in young children
Severe Knowlesi Malaria
P. knowlesi replicates every 24 h rapidly increasing parasite densities
Severe disease and death in some
Severe disease are similar to severe falciparum malaria, with the exception of coma
Patients with P. malariae-like infections (band form) and unusually high parasite densities (parasitemia > 0.5% by microscopy) should be managed as P. knowlesi infection
Definitive diagnosis is made by PCR
Antimalarial Drug Activity in the Life Cycle of Plasmodia
Treat Acute attack- Artesunate- Quinine- Mefloquine- Chloroquine- Tetracycline- Atovaquone- Proguanil
Prevent relapse
Primaquine, proguanil, tetracycline
Prevent
transmission
Primaquine,
Artemisinines
2/21/2018
10
RCPT MoPH
First-line drugs
Artesunate 4 mg/kg/day for 3 days+ mefloquine 25 mg /kg in divided dose
( 3 tabs then 2 tabs)
Second-line drugs
Quinine 10 mg /kg + doxycycline 3 mg/kg OD or BID, or clindamycin 10 mg/kg/ bid 7 days
Artesunate 2 mg/kg/day + doxycycline 3 mg/kg OD or BID, or clindamycin 10 mg/kg/ bid 7 days
Followed by
Primaquine 30 mg once
Dihydroartemisinin (DHA)-Piperaquine (40/320 mg) 3 days <60 Kg 3 tabs OD
60-80 Kg 4 tabs OD
> 80 Kg 5 tabs OD
Followed by
Primaquine 30 mg once
Treatment of Uncomplicated Falciparum Malaria
Artemisinin combination therapy (ACT)
- Artesunate+mefloquine
- DHA-piperaquine
Treatment of Uncomplicated Malaria
Pregnant woman
Quinine+clindamycin (alternative DHA-pip) (MoPH)
Second or third trimester
Artesunate (RCPT)
DHA-piperaquine (MoPH)
Do not use doxycycline or primaquine (even single dose)
Relapsed Pf malaria within 2 months- do not use mefloquine
Use quinine+doxy/clinda or artesunate+doxy/clinda
Treatment of Uncomplicated Malaria
Non- P. falciparum
Chloroquine 4-4-2 tabs (total 10 tabs)
Primaquine for Pv and Po
15 mg OD for 14 day (unknown G-6-PD)
30 mg OD for 14 day (if no G-6-PD deficiency)
45 mg weekly for 8 weeks (if mild G-6-PD deficiency)
Pregnant women
Chloroquine 300 mg weekly suppressive therapy for PV and PO in pregnant women until postpartum then use primaquine
Treatment of Severe Malaria
First-line drugs
Artesunate IV
2.4 mg/kg IV PUSH at 0, 12, and 24 h Day 1 then 2.4 mg/kg once a day, if improved
Change to oral ACT for 3 days (DHA-pip; MoPH, Artesunate-mef; RCPT)
Second-line drugs
Quinine IV
Loading 20 mg/kg IV DRIP > 4 h then 10 mg/kg IV DRIP in 2-4 h q 8 h, if improved
Change to oral ACT for 3 days (DHA-pip; MoPH, Artesunate-mef; RCPT) or
Change to quinine+doxy/clinda or artesunate+doxy/clinda for 7 days
•Doxycycline can be given once daily, starts when the patient has recovered sufficiently•Mefloquine should be avoided due to risk of neuropsychiatric complications in the patient presented initially with impaired consciousness
A 18 years old male, no underlying disease What is the diagnosis ?
A. Infective endocarditis
B. Leptospirosis
C. Dengue hemorrhagic fever
D. Gram-negative sepsis with DIC
E. Scrub typhus
2/21/2018
11
Leptospirosis
Leptospira interrogans
Reservoir: 160 mammals, most important-rodent esp. rat (shed in urine)
Transmission: skin contact with water, soil
Incubation period: 2-26 days (average 10 days)
Four broad clinical categories
(i) a mild, influenza-like illness
(ii) Weil's syndrome characterized by jaundice, renal failure, haemorrhage and myocarditis with arrhythmias
(iii) meningitis/meningoencephalitis
(iv) pulmonary haemorrhage with respiratory failure
Clinical Manifestations
Subclinical infection 40-70%
Symptomatic cases – 90% mild or anicteric form
Acute febrile illness with a biphasic course (leptospiremic and immune phases) - good prognosis
Nonspecific signs and symptoms (flu-like)
Severe or icteric leptospirosis (Weil disease)– 10%
Mortality 10%
Multiple organ involvement
Loss of biphasic fever
Anicteric leptospirosis Icteric leptospirosis
(Incubation
period 2-20
days)
Fever
Leptospiremicphase
3-7 days
Immune phase
0-30 days
Leptospiremic phase
3-7 days
Immune phase
0-30 days
Associated symptoms
Myalgia
Headache
Nausea,
Vomiting
Abdominal pain
Conjunctival suffusion
Meningitis
Uveitis
Rash
Jaundice
Hemorrhage
Acute renal failure
Myocarditis
Hemorrhagic pneumonitis
Meningoencephalitis
Hypotension
Leptospires present in
Blood Blood
CSF CSF
Urine Urine
Clinical Course
Siriluck Anunnatsiri (with permission)
Diagnosis
Antibody detection (IgG, IgM) IFA
Need 4-fold rising for diagnosis
Single cutoff titer varies (for IFA ≥ 1:400)
PCR
Treatment
Mild leptospirosis
Doxycycline, ampicillin, or amoxicillin
Severe leptospirosis
Intravenous penicillin G - drug of choice
Third-generation cephalosporins: cefotaxime and ceftriaxone
2/21/2018
12
A 42 years old
A farmer
Fever with headache for 10 day
Myalgia
The diagnosis is…….
Scrub typhus
Rickettsioses
Spotted fever group (15 rickettsioses) Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii
Rickettsialpox caused by Rickettsia akari
Thailand: Thai tick typhus (R. honei)
R. helvetica , R. conorii, R. felis
Typhus group Epidemic (louse-borne) typhus caused by Rickettsia prowazekii
Endemic (murine) typhus caused by Rickettsia typhi
Scrub typhus group Caused by Orientia tsutsugamushi
Clinical Characteristics
Small, painless, gradually enlarging papule, which leads to an area of central necrosis and is followed
by eschar formation (30-50%)
At axilla, perineum, groin, under breast line
Chigger Eschar
Eschars
Cutaneous anthrax Plague
Scrub typhus Ecthyma grangrenosum
Severe Scrub Typhus
Pneumonitis, ARDS
Encephalitis, aseptic meningitis
Rarely, acute renal failure, shock, and disseminated intravascular coagulation (DIC)
Cardiac involvement is often minor and rare, but can cause fatal myocarditis
Severe Scrub Typhus
Pneumonitis, ARDS
Encephalitis, aseptic meningitis
Rarely, acute renal failure, shock, and disseminated intravascular coagulation (DIC)
Cardiac involvement is often minor and rare, but can cause fatal myocarditis
2/21/2018
13
Diagnosis and Treatment
Diagnosis: Serology by IFA
- IgM titer ≥ 1:400, IgG titer ≥ 1:1,600 or
- 4-fold rising 14 D apart with titer ≥ 1:200
Treatment:
- Doxycycline 100 mg po bid 3 days after symptoms resolve
- Azithromycin (in pregnancy or IV azithromycin in severe form)
Murine typhus
Headache, fever, muscle pain, joint pain, nausea and vomiting
MP rash 40-50% - about six days after the onset
Neurological signs 45% - confusion, stupor, seizures or imbalance
Symptoms may resemble those of measles or rubella
Investigation and treatment
Same as scrub typhus
A woman with severe murine typhus and ARDS
วราภรณ์ วิมลสริิสุข,วราภรณ์ วิมลสริิสุข,
WARAPORN WIMOLSIRISUKWARAPORN WIMOLSIRISUK
5333247553332475
20/12/250120/12/2501
Age: 56 YEARAge: 56 YEAR
FF
Page: 1 of 1Page: 1 of 1
SIRIRAJ HOSPITAL (PORTABLE)SIRIRAJ HOSPITAL (PORTABLE)
CHESTCHEST
8/2/2558 6:31:498/2/2558 6:31:49
2366515623665156
------
------
------
IM: 1001IM: 1001
W: 1024W: 1024C: 512C: 512Z: 0.58Z: 0.58S: 552S: 552
cm
cm
วราภรณ์ วิมลสริิสุข,วราภรณ์ วิมลสริิสุข,
WARAPORN WIMOLSIRISUKWARAPORN WIMOLSIRISUK
5333247553332475
20/12/250120/12/2501
Age: 56 YEARAge: 56 YEAR
FF
Page: 1 of 1Page: 1 of 1
SIRIRAJ HOSPITAL(R228)SIRIRAJ HOSPITAL(R228)
CHESTCHEST
12/2/2558 10:38:2612/2/2558 10:38:26
2367091423670914
------
------
------
IM: 1001IM: 1001
W: 1024W: 1024C: 512C: 512Z: 0.48Z: 0.48S: 310S: 310
cm
cm
5 days after treatment
A man post liver transplantation
Date 17/6/56 18/6/56 19/6/56 20/6/56 21/6/56 22/6/56 23/6/56
Meropenem
Vancomycin
Ganciclovir
Cotrimoxzole
• CMV viral load < 20 copies/mL
• Serum gallactomanan: negative • Serum cryptococcus Ag: negative
Bronchoscopy
Lab 18/6/56 23/6/56
Hb (g/dL)/Hct(%)
12.1/35.1 9.6/28.1
WBC (/mm3) 6,140 3,130
N (%) 92.5 62
L (%) 5 27.8
M (%) 2.3 8.9
E (%) 0 0.3
B (%) 0.2 1
Platelets (/mm3) 56,000 93,000
BUN/Cr (mg/dL) 14.6/1.42 28.1/2.22
TB/DB (mg/dL) 0.5/0.31 0.9/0.8
AST/ALT (mg/dL)
55/38 1,545/488
ALP (U/L) 96 616
Alb/Glob (mg/dL)
2.6/2.5 2.1/3.1
Date 19/6/56
IFA (IgG+M) Leptospira spp.
IgG <1:50
IgM <1:50
IFA (IgG+M) O. tsutsugamushi
IgG <1:50
IgM <1:50
IFA (IgG+M) R. typhi
IgG 1:800
IgM 1:800
A man post liver transplantation Intestinal nematodes
Trichuris trichiura
Chronic diarrheaRectal prolapse
Enterobius vermicularis
AsymptomaticAutoinfection
Ascaris lumbricoides
Abdominal painSmall bowel obstruction Lung migration (larva)- Eosinophilic
pneumonitis (LÖffler’s syndrome)
Hookworm
Abdominal pain, Iron-def anemia
Treatment: Albendazole 400 mg x 1 day
2/21/2018
14
Capillaria philippinensis
Undercooked fish
Symptoms
Chronic voluminous diarrhea
Malabsorption syndrome
Size 40x20 µ
Dx
Peanut-shaped egg
Flatten bipolar plugs
Rx
Albendazole 400 mg PO x 10 D
Mebendazole 200 mg BID x 20 D
Strongyloides stercoralis
Acute infection:
1/3 - asymptomatic
larva currens, LÖffler’s syndrome, diarrhea
Chronic persisting infection: 1/3-asymptomatic
Triad: urticaria, abdominal pain, diarrhea
Hyperinfection syndrome: Exacerbation of GI, pulmonary symptoms and increased numbers of larvae in stool and sputum
Complication: Gram negative bacteremia
Rx - Ivermectin 200 µg/kg PO ODx2d
: For hyperinfection: repeat treatment every 15 days while stool positive,
then 1 more treatment cycle
: Hyperinfection in immunocompromised: 200 µg/kg OD until neg. for 2 wks
- Albendazole 400 mg PO BID x 7 d (less effective)
Gnasthostoma spinigerum
Eating Raw fish or contaminated water with cyclops
Larval gnasthostomiasis
Intermittent subcutaneous migratory swelling
Ocular gnathostomiasis
Eosinophilic myeloencephalitis
Dx: antibody detection (ELISA)
Rx: Surgery
Albendazole 400 mg/d x 21 d or
Ivermectin 150-200 µg/kg single dose
J Travel Med. 2016;24(1). doi:10.1093/jtm/taw074
Angiostrongylus cantonensis
Angiostrongyliasis
Eosinophilic meningoencephalitis
Dx: antigen detection (ELISA)
Rx: No specific treatment, CSF removal
Prednisolone 60 mg/day x 14 days
Undercooked snails,crabs,
freshwater shrimps
Third stage larvae
Visceral Larva Migrans
Ingest egg of dog/cat ascarids
Toxocara canis, Toxocara cati
Mostly asymptomatic
Visceral /ocular larva migrans
Dx: Toxocara antibody (ELISA)
Rx: Supportive
Prednisolone
Albendazole 800 mg bid x 5-20 d (intestinal parasites only)
Cutaneous Larva Migrans
- Raised, erythematous, serpiginous, tunnel-like lesion 2-3 mm
- Containing serous fluid
Etiology
Ancylostoma braziliense (cat, dog hookworm) Ancylostoma caninum(dog hookworm)
Human hookworm
Strongyloides stercoralis (larva currens)
Rx: - Albendazole 200-400 mg PO bid x 3-5 d
- Ivermectin 200 mcg/kg PO once
2/21/2018
15
Taeniasis
Eat undercooked pork (cysticercus cellulosae)
Taenia solium(pork tapeworm)
Eat undercooked beef(cysticercus bovis)
Taenia saginata(beef tapeworm)
Rx of intestinal parasite:- Praziquantel 10 mg/kg PO once
Taenia egg:Diameter 40 µ
Round shaped-eggThick shell with radial striation
Eat Taenia solium egg or autoinfection
Neurocysticercosis
Vesicular cyst Colloidal cyst
Granular stage Calcifications
Cysticercosis
Multiple rice-grain like cacification
Treatment of Neurocysticercosis
Anticonvulsant therapy: mainstay of management of neurocysticercosis-associated seizure disorders
Antiparasitic therapy
Symptomatic patients with multiple, live cysticerci cyst reduction, fewer and decreased seizure recurrences
Not benefit in patients with calcified cysts
Concomitant steroids
Dexamethasone 0.1 mg/kg/d 1 day prior antiparasitic drugs x10 D
Combined albendazole (15 mg/kg /day) plus praziquantel (50 mg/kg/ day)
Higher rate of complete resolution of brain cysts at 6 mo compared to standard dose of albendazole (64% vs. 37%, RR 1·75, 95% CI 1·10–2·79, p=0·014)
Flukes
Paragonimus westermani
Paragonimus heterotremus
Eat metacercaria in undercooked shrimp, crab
Symptoms
Pulmonary paragonimiasis
Cerebral and spinal paragonimiasis
Migratory subcutaneous paragonimiasis
Rx: Praziquantel 25 mg/kg PO tid x 2 D
Opisthorchis viverrini
Undercooked fish
Symptoms
Early: asymptomatic
Abdominal pain
Relapsing cholangitis
Cholangiocarcinoma
Rx: Praziquantel 25 mg/kg PO tid x 2 days
Fasciolopsis buski
Giant intestinal fluke (largest human parasite)
Eat water contaminated with metacercaria
Symptoms
abdominal pain and diarrhea
Rx: Praziquantel 25 mg/kg PO tid x 1 days
Liver fluke Intestinal fluke Lung fluke
Schistosomiasis (Blood flukes)
Mesenteric venule:
S. japonicum, S. mansoni, S. mekongi
Venule of lower urinary tract :
S. haematobium
Thailand: S. japonicum
Clinical form:
- Schistosome dermatitis
- Acute schistosomiasis:2-8 wks
- Chronic schistosomiasis
Schistosoma mansoni- Non-operculum, oval
- Lateral spine
Schistosoma haematobium- Non-operculum, oval
- Terminal spine
Schistosoma japonicum- Non-operculum, round
- Lateral knob
Schistosoma mekongi- Non-operculum, round
- Lateral knob
Rx: Praziquantel 20 mg/kg PO TID x 1 d
Rx: Praziquantel 20 mg/kg PO BID x 1 d
Intestinal Protozoa
Protozoa Treatment
Cryptosporidium spp. No effective treatment (Nitazoxanide)
Cyclospora cayetanensis,
Cystoisospora belli
TMP-SMX DS 1 tab bid x 7-10 days
HIV: TMP-SMX DS 1 tab qid x 3-4 weeks
Giardia lambia Tinidazole 2 g po x 1
Metronidazole 250 mg po tid x 5-7 days
Albendazole 400 mg po OD x 5 days
Cryptosporidium parvum
4-6 µM 6-10 µM 15-30 µM
Giardia lambia
10-14 µM
Cystoisosporabelli
Cyclosporacayetanensis